Revvity (NYSE:RVTY) CAO Sells 84 Shares of Company Stock

Key Points

• Revvity CAO Anita Gonzales sold 84 shares at an average price of $155.48, reducing her holdings by 1.17% to 7,117 shares valued at approximately $1.11 million.
• Revvity shares rose 1.6% to $151.46, near their 52-week high, after the company reported quarterly earnings and revenue above analyst expectations. Management maintained fiscal 2026 guidance of $5.30–$5.40 in earnings per share.
• The company declared a quarterly dividend of $0.07 per share, equivalent to an annualized $0.28 dividend and a 0.2% yield. Analysts collectively rate the stock “Hold,” with a consensus price target of $116.57.

Revvity Inc. (NYSE:RVTY - Get Free Report) CAO Anita Gonzales sold 84 shares of the stock in a transaction on Thursday, October 1st. The shares were sold at an average price of $155.48, for a total value of $13,060.32. Following the sale, the chief accounting officer owned 7,117 shares in the company, valued at $1,106,551.16. The trade was a 1.17% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link.

Anita Gonzales also recently made the following trade(s):

• On Monday, July 20th, Anita Gonzales sold 85 shares of Revvity stock. The stock was sold at an average price of $109.48, for a total value of $9,305.80.

Revvity Trading Up 1.6%

NYSE RVTY traded up $2.40 on Friday, hitting $151.46. 1,235,180 shares of the stock were exchanged, compared to its average volume of 1,499,707. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.50 and a current ratio of 1.80. Revvity Inc. has a 52-week low of $81.22 and a 52-week high of $158.28. The firm has a market capitalization of $16.90 billion, a P/E ratio of 72.13, a P/E/G ratio of 2.78 and a beta of 1.06. The stock has a fifty day moving average price of $127.45 and a two-hundred day moving average price of $108.40.

Revvity (NYSE:RVTY - Get Free Report) last announced its earnings results on Tuesday, August 4th. The company reported $1.41 earnings per share for the quarter, beating the consensus estimate of $1.21 by $0.20. The business had revenue of $729.69 million for the quarter, compared to the consensus estimate of $702.96 million. Revvity had a net margin of 8.16% and a return on equity of 8.34%. The business's revenue for the quarter was down 1.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.18 earnings per share. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. Research analysts forecast that Revvity Inc. will post 5.36 EPS for the current fiscal year.

Revvity Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Friday, October 23rd will be issued a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a yield of 0.2%. The ex-dividend date is Friday, October 23rd. Revvity's dividend payout ratio is presently 13.33%.

Wall Street Analyst Weigh In

RVTY has been the subject of several analyst reports. UBS Group assumed coverage on shares of Revvity in a research note on Wednesday, September 9th. They issued a "neutral" rating and a $140.00 price objective for the company. Weiss Ratings upgraded Revvity from a "sell (d+)" rating to a "hold (c-)" rating in a report on Thursday, July 30th. Evercore reiterated an "outperform" rating on shares of Revvity in a report on Wednesday, August 5th. Sanford C. Bernstein assumed coverage on Revvity in a research note on Friday, June 26th. They set a "market perform" rating and a $115.00 price target for the company. Finally, TD Cowen restated a "buy" rating on shares of Revvity in a report on Wednesday, July 15th. Four equities research analysts have rated the stock with a Buy rating and fourteen have issued a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $116.57.

Institutional Investors Weigh In On Revvity

Several large investors have recently added to or reduced their stakes in RVTY. Jupiter Topco LLC purchased a new position in shares of Revvity during the second quarter worth approximately $961,017,000. BlackRock Inc. purchased a new stake in shares of Revvity in the second quarter valued at approximately $852,070,000. Janus Henderson Group PLC grew its stake in Revvity by 7.0% in the fourth quarter. Janus Henderson Group PLC now owns 8,161,171 shares of the company's stock worth $789,595,000 after purchasing an additional 533,912 shares in the last quarter. EdgePoint Investment Group Inc. grew its stake in Revvity by 3.1% in the first quarter. EdgePoint Investment Group Inc. now owns 8,800,863 shares of the company's stock worth $771,044,000 after purchasing an additional 265,204 shares in the last quarter. Finally, State Street Corp increased its holdings in Revvity by 0.8% during the 2nd quarter. State Street Corp now owns 4,342,739 shares of the company's stock worth $483,173,000 after purchasing an additional 32,426 shares during the period. 86.65% of the stock is owned by hedge funds and other institutional investors.

About Revvity

Revvity, Inc NYSE: RVTY is a life sciences and diagnostics company that provides technologies, products and services used in biological research, drug discovery, clinical testing and healthcare. The company serves pharmaceutical and biotechnology companies, academic and government research institutions, hospitals, clinical laboratories and other healthcare organizations.

Its portfolio includes instruments, reagents, consumables, software and related services for areas such as genomics, proteomics, cellular analysis, imaging and multiplex testing.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.